Follow
Suzanne L Parker
Suzanne L Parker
Verified email at uq.edu.au
Title
Cited by
Cited by
Year
What is the relevance of fosfomycin pharmacokinetics in the treatment of serious infections in critically ill patients? A systematic review
S Parker, J Lipman, D Koulenti, G Dimopoulos, JA Roberts
International journal of antimicrobial agents 42 (4), 289-293, 2013
742013
Population pharmacokinetics of fosfomycin in critically ill patients
SL Parker, F Frantzeskaki, SC Wallis, C Diakaki, H Giamarellou, ...
Antimicrobial Agents and Chemotherapy 59 (10), 6471-6476, 2015
692015
The effect of renal replacement therapy and antibiotic dose on antibiotic concentrations in critically ill patients: data from the multinational sampling antibiotics in renal …
JA Roberts, GM Joynt, A Lee, G Choi, R Bellomo, S Kanji, MY Mudaliar, ...
Clinical Infectious Diseases 72 (8), 1369-1378, 2021
552021
Optimizing dosing of antibiotics in critically ill patients
SL Parker, FB Sime, JA Roberts
Current Opinion in Infectious Diseases 28 (6), 497-504, 2015
412015
Quantitative bioanalytical validation of fosfomycin in human whole blood with volumetric absorptive microsampling
SL Parker, JA Roberts, J Lipman, SC Wallis
Bioanalysis 7 (19), 2585-2595, 2015
392015
A simple LC–MS/MS method using HILIC chromatography for the determination of fosfomycin in plasma and urine: application to a pilot pharmacokinetic study in humans
SL Parker, J Lipman, JA Roberts, SC Wallis
Journal of Pharmaceutical and Biomedical Analysis 105, 39-45, 2015
322015
Population pharmacokinetics of unbound ceftolozane and tazobactam in critically ill patients without renal dysfunction
FB Sime, M Lassig-Smith, T Starr, J Stuart, S Pandey, SL Parker, ...
Antimicrobial Agents and Chemotherapy 63 (10), e01265-19, 2019
302019
Clinical application of microsampling versus conventional sampling techniques in the quantitative bioanalysis of antibiotics: a systematic review
YC Guerra Valero, SC Wallis, J Lipman, C Stove, JA Roberts, SL Parker
Bioanalysis 10 (6), 407-423, 2018
292018
Effect of time on recovery of plasma microsamples for the quantitative determination of vancomycin
SL Parker, YC Guerra Valero, J Lipman, JA Roberts, SC Wallis
Bioanalysis 8 (21), 2235-2242, 2016
292016
Uncertainty in antibiotic dosing in critically ill neonate and pediatric patients: can microsampling provide the answers?
T Dorofaeff, RM Bandini, J Lipman, DE Ballot, JA Roberts, SL Parker
Clinical therapeutics 38 (9), 1961-1975, 2016
292016
A validated method for the quantification of fosfomycin on dried plasma spots by HPLC–MS/MS: Application to a pilot pharmacokinetic study in humans
SL Parker, J Lipman, G Dimopoulos, JA Roberts, SC Wallis
Journal of Pharmaceutical and Biomedical Analysis 115, 509-514, 2015
282015
The use and risks of antibiotics in critically ill patients
KJ Denny, MO Cotta, SL Parker, JA Roberts, J Lipman
Expert Opinion on Drug Safety 15 (5), 667-678, 2016
252016
A population pharmacokinetic model-guided evaluation of ceftolozane-tazobactam dosing in critically ill patients undergoing continuous venovenous hemodiafiltration
FB Sime, M Lassig-Smith, T Starr, J Stuart, S Pandey, SL Parker, ...
Antimicrobial agents and chemotherapy 64 (1), e01655-19, 2019
222019
Population pharmacokinetics of total and unbound concentrations of intravenous posaconazole in adult critically ill patients
FB Sime, CJ Byrne, S Parker, J Stuart, J Butler, T Starr, S Pandey, ...
Critical Care 23 (1), 1-12, 2019
212019
Ex Vivo Characterization of Effects of Renal Replacement Therapy Modalities and Settings on Pharmacokinetics of Meropenem and Vaborbactam
FB Sime, S Pandey, N Karamujic, S Parker, E Alexander, J Loutit, S Durso, ...
Antimicrobial Agents and Chemotherapy 62 (10), e01306-18, 2018
212018
A UHPLC–MS/MS method for the simultaneous determination of piperacillin and tazobactam in plasma (total and unbound), urine and renal replacement therapy effluent
S Naicker, YCG Valero, JLO Meija, J Lipman, JA Roberts, SC Wallis, ...
Journal of Pharmaceutical and Biomedical Analysis 148, 324-333, 2018
212018
Determination of cefalothin and cefazolin in human plasma, urine and peritoneal dialysate by UHPLC‐MS/MS: Application to a pilot pharmacokinetic study in humans
SL Parker, YC Guerra Valero, DM Roberts, J Lipman, JA Roberts, ...
Biomedical Chromatography 30 (6), 872-879, 2016
212016
Is there a role for microsampling in antibiotic pharmacokinetic studies?
SL Parker, T Dorofaeff, J Lipman, DE Ballot, RM Bandini, SC Wallis, ...
Expert Opinion on Drug Metabolism & Toxicology 12 (6), 601-614, 2016
192016
Lung pharmacokinetics of tobramycin by intravenous and nebulized dosing in a mechanically ventilated healthy ovine model
JA Dhanani, S Diab, J Chaudhary, J Cohen, SL Parker, SC Wallis, ...
Anesthesiology 131 (2), 344-355, 2019
152019
Intravenous fosfomycin for the treatment of multidrug-resistant pathogens: what is the evidence on dosing regimens?
G Dimopoulos, D Koulenti, SL Parker, JA Roberts, K Arvaniti, G Poulakou
Expert Review of Anti-infective Therapy 17 (3), 201-210, 2019
122019
The system can't perform the operation now. Try again later.
Articles 1–20